Dr. Arielle Selya is a behavioral science consultant specializing in tobacco harm reduction. Through her primary role as Senior Scientist at PinneyAssociates, Inc., she supports Juul Labs, Inc. in their scientific and regulatory efforts through behavioral study protocols, statistical methodology, and scientific publishing strategy and execution. Dr. Selya is also a consultant to the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) on e-cigarette use behavioral research and critical analysis of scientific literature. She received her PhD in Neuroscience at Rutgers University and, prior to becoming a consultant, spent a decade in academia studying adolescent substance use and addiction. In addition to being a prolific contributor to the scientific literature, with over 70 scientific publications to her name, Dr. Selya is also actively engaged in both post-publication critiques of published research and in communicating scientific findings to broader audiences (see her collection of tweetorials here).
All videos (2)
#GFN25 Science Discussion #17 | How to Avoid Pitfalls in Observational E-Cigarette Health Research
16 Mar 2026
Dr Arielle Selya presents a review of the common flaws in observational research on e-cigarette use and discusses the impact that these flaws have on study conclusions. Dr Selya offers suggestion on how future studies in the field could be improved. #GFN25ScienceLab
GFN News #175 | What the Research on Vaping and Harm Reduction Really Says?
9 Feb 2026
Behavioral science consultant Arielle Selya joins GFN News to discuss her new YouTube channel and why she’s breaking down tobacco harm reduction research. From misperceptions about vaping to the gateway hypothesis, she explains what the science actually shows—and how studies are often misrepresented.